Infantile Kaposiform hemangioendothelioma in a female patient complicated with severe obstructed jaundice: a case report
Surgical Case Reports volume 8, Article number: 225 (2022)
Kaposiform hemangioendothelioma (KHE) is a rare locally aggressive vascular neoplasm that occurs mainly in the pediatric population. KHE usually originates just underneath the skin and affects deeper tissues through infiltrative growth; however, visceral tissue involvement is quite rare.
An 8-month-old girl with jaundice and acholic stool was referred to our hospital for further evaluation of a hepatoduodenal ligament tumor. A blood examination revealed high bilirubin and liver enzyme levels, but no signs of coagulopathy. The first attempt at a diagnostic surgical procedure did not provide sufficient diagnostic information. However, the histopathological diagnosis of the cystic duct excised in the second surgery indicated KHE. Therefore, in our case, KHE was considered a cause of obstructive jaundice. Sirolimus (rapamycin) was initiated, and the patient was discharged 7 months after admission.
In cases of atypical hypervascular lesions in the abdominal cavity, especially in the pediatric population, it is important to consider the possibility of KHE, and surgical intervention with proper strategies is required for diagnosis, followed sequentially by promising treatments.
Kaposiform hemangioendothelioma (KHE), first described in 1993 by Zukerberg , is a rare disease, locally aggressive vascular neoplasm that mainly occurs in the pediatric population . KHE usually originates just beneath the skin and usually affects deeper tissues by infiltrative growth; however, visceral tissues involvement is quite rare. Several KHE cases with bone, retroperitoneal, or mediastinal involvement have been described . We encountered a very rare case of infantile KHE complicated by obstructive jaundice. Herein, we present its difficult diagnosis.
An 8-month-old female patient with jaundice and acholic stool was taken to a hospital, where blood examinations revealed elevated liver enzyme (aspartate transaminase/alanine transaminase [AST/ALT], 254/161 U/L) and bilirubin (total, 5.6 mg/dL) levels without signs of coagulopathy. Abdominal computed tomography and magnetic resonance imaging showed a large hypervascular tumor arising from the hepatoduodenal ligament (HDL) (Fig. 1). She was referred to our hospital with obstructive jaundice due to a tumor originating from the HDL.
To diagnose the tumor, we performed an exploratory laparotomy on hospital day 2. No tumor-like lesions were observed in the upper abdominal cavity. The HDL became edematous and hard and bled easily, indicating acute inflammation. En bloc surgical excision of the lesion is considered associated with a risk of injury to the bile duct, hepatic artery, and portal vein. Therefore, a liver biopsy and sampling of the HDL and lymphoid tissue around the neck of the gall bladder were performed. However, these surgical procedures did not provide a definitive diagnosis.
Despite the initiation of oral corticosteroid treatment, the jaundice did not subside (total/direct bilirubin, 9.1/6.6 mg/dL), and the AST/ALT levels were elevated (322/260 U/L). The dilatation of the intrahepatic bile duct gradually became exacerbated, and the gallbladder became quite large and palpable over the surface of the abdominal wall. Spontaneous rupture of the gallbladder is a cause for concern. Therefore, on postoperative day 32, the patient underwent a biopsy of the lesion and a cholecystectomy.
The HDL became soft and less edematous but bled easily, indicating subacute inflammation. Despite a detailed observation, no obvious lesions were observed in the abdominal cavity. Intraoperative cholecystography revealed that the cystic duct (CD) was completely obstructed, and intraoperative intrahepatic cholangiography revealed that the bile duct around the junction of the CD narrowed along the HDL. Obvious lesions were difficult to obtain; therefore, a cholecystectomy with CD resection as distally as possible, liver biopsy, and no. 12b lymphoid tissue sampling were performed. To improve the severe obstructive jaundice, a hepaticojejunostomy in a Roux-en-Y fashion was performed in which the jejunum was anastomosed to the ventral wall of the common hepatic duct (CHD) (Fig. 2). Almost all the lesions remained in the second surgery.
Hypervascular and polynodular lesions were observed around the resected CD close to the HDL in which proliferating spindle cells formed slit-like lumens filled with red blood cells. Immunohistochemical staining demonstrated that the spindle cells were positive for CD31, CD34, and ERG, partially positive for D2-40 and Prox1, and negative for GLUT1. These findings are consistent with those of KHE (Fig. 3).
Postoperative clinical course
The patient’s obstructive jaundice improved rapidly after the hepaticojejunostomy during the second surgical intervention. In contrast, the amount of ascites was significantly increased in the early postoperative period, and the ascites were presumed to comprise chyle and lymph fluids. With symptomatic therapy, the oral administration of 0.5 mg/day (0.06 mg/kg/day) sirolimus (rapamycin) was started as a first-line therapy on postoperative day 24 (trial registration jRCTs031180290). The large amount of ascites gradually decreased, and the hepatic and Winslow drainage tubes were removed at 83 and 90 days postoperative, respectively. The KHE lesion was slightly reduced (Fig. 4). The patient was discharged 7 months after admission.
KHE is a rare locally aggressive vascular neoplasm that occurs mainly in the pediatric population . KHE usually originates just beneath the skin and affects deeper tissues through infiltrative growth; however, visceral tissue involvement is quite rare. Although KHE may involve various organs such as bone, retroperitoneum, and mediastinum, involvement of the choledochus is rare [2, 3].
To the best of our knowledge, five cases of KHE originating from the HDL area have been reported in English (Table 1). Terui et al. reported the case of a 5-month-old boy who was successfully treated with hepatoportoenterostomy . In contrast, Mathew et al. reported a demised case of an 8-month-old female infant . In addition, Yao et al. reported three clinically diagnosed cases in male patients with obstructive jaundice and Kasabach–Merritt phenomenon (KMP), all of whom were successfully diagnosed without surgical intervention and administered sirolimus (rapamycin) as primary treatment. Their clinical course was satisfactory with no additional surgical interventions [5, 6].
In most cases, KHE is associated with consumptive KMP or lymphangiomatosis , and these clinical symptoms could be diagnostic clues that lead to the diagnosis of KHE, even in atypical cases . In our case, KHE was not considered until the histopathological diagnosis was demonstrated because our case did not show coagulopathy or distinct lymphangiomatosis. However, in cases of atypical visceral tissue involvement without typical clinical symptoms, it is important to consider KHE in the differential diagnosis.
Regarding the treatment of KHE, definitive treatment guidelines are unavailable due to the very low incidence of this disease. Corticosteroids are often used as first-line therapy; however, they feature some adverse effects such as hypertension, a cushingoid appearance, growth retardation, and opportunistic infections, and they are infrequently effective as solitary agents. Wang et al. suggested vincristine (VCR), an inhibitor of endothelial proliferation, as a first-line treatment for steroid-resistant cases . Sirolimus (rapamycin), an mTOR pathway inhibitor, was recently identified as beneficial for patients with KHE and VCR-resistant and -refractory or recurrent life-threatening KMP . In our case, silorimus (rapamycin) was administered after KHE was diagnosed, and the clinical symptoms, such as postoperative ascites, gradually improved. Therefore, the oral administration of sirolimus (rapamycin) is considered effective for complicated KHE originating from HDL.
In addition, surgical excision could be an effective therapeutic option; however, this is not always possible due to the disease location, infiltrative pattern of these tumors, and presence of thrombocytopenic coagulopathies . In our case, liver transplantation (LT) was considered for surgical excision of the tumor; however, the liver was not cirrhotic; thus, LT was considered the last therapeutic option.
For the rescue of the obstructive jaundice, surgical interventions such as percutaneous transhepatic cholangiodrainage (PTCD) and hepaticojejunostomy were considered. If PTCD was selected instead of hepaticojejunostomy, some troubles such as infection and obstruction of the drainage tube were encountered in the long course of hospitalization. In our case, a hepaticojejunostomy effectively reduced the obstructive jaundice. The jejunum was anastomosed to the ventral wall of the CHD because the tumor infiltrated the HDL and it was quite challenging to expose the CHD without intraoperative complications. However, our modification was reflected in the postoperative course, and CD resection as distally as possible was a definitive factor for the diagnosis. Therefore, if obstructive jaundice is caused by a tumor of unknown origin inside the HDL, these challenges could become diagnostic clues followed by definitive treatment.
We encountered a very rare case of intra-abdominal KHE complicated by severe obstructive jaundice. Unless there are no signs of KMP or lymphangiomatosis, in cases of atypical hypervascular lesions in the abdominal cavity, especially among infants, it is important to consider the possibility of KHE, and surgical intervention with proper strategies is required for the diagnosis, followed by promising treatment.
Availability of data and materials
Common hepatic duct
Percutaneous transhepatic biliary drainage
Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17(4):321–8.
Fernandez Y, Bernabeu-Wittel M, Garcia-Morillo JS. Kaposiform hemangioendothelioma. Eur J Intern Med. 2009;20(2):106–13.
Terui K, Nakatani Y, Kambe M, Fukunaga M, Hishiki T, Saito T, et al. Kaposiform hemangioendothelioma of the choledochus. J Pediatr Surg. 2010;45(9):1887–9.
Mathew D, Mahomed N. Pancreatic kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: a rare entity. SA J Radiol. 2019;23(1):1760.
Yao W, Li K, Wang Z, Dong K, Zheng S. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: a retrospective series of 3 patients treated with sirolimus. Pediatr Dermatol. 2020;37(4):677–80.
Hase T, Kodama M, Kishida A, Matsushita M, Kurumi Y, Mizukuro T, et al. Successful management of infantile hepatic hilar hemangioendothelioma with obstructive jaundice and consumption coagulopathy. J Pediatr Surg. 1995;30(10):1485–7.
Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Pediatr Blood Cancer. 2015;62(4):577–80.
The authors thank the patient, the patient’s parents, and all staffs in the National Center for Child Health and Development for their contribution. Finally, they thank Michio Ozeki, M.D., Ph.D. from Gifu University and AMED under Grant Number JP22ek0109515 for clinical use of Sirolimus (rapamycin).
The authors declare that they have not received any funding for this study.
Ethics approval and consent to participate
This study was approved by the ethics committee of National Center for Child Health and Development.
Consent for publication
Informed consent was obtained from the parents for publication of this case report.
The authors have no competing interests associated with this manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Watanabe, E., Hashizume, N., Yoneda, A. et al. Infantile Kaposiform hemangioendothelioma in a female patient complicated with severe obstructed jaundice: a case report. surg case rep 8, 225 (2022). https://doi.org/10.1186/s40792-022-01581-9